Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

BACKGROUND: New chemotherapy regimens for patients with colorectal cancer have improved survival, but at the cost of clinical toxicity. Oxaliplatin, an agent used in first-line therapy for metastatic colorectal cancer, causes acute and chronic neurotoxicity. This study was performed to carefully ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonard, Gregory D, Wright, Maurice A, Quinn, Mary G, Fioravanti, Suzanne, Harold, Nancy, Schuler, Barbara, Thomas, Rebecca R, Grem, Jean L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266024/
https://www.ncbi.nlm.nih.gov/pubmed/16168057
http://dx.doi.org/10.1186/1471-2407-5-116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266024/
https://www.ncbi.nlm.nih.gov/pubmed/16168057
http://dx.doi.org/10.1186/1471-2407-5-116

Ejemplares similares